A POSSIBLE MODALITY OF INTERVENTION IN A SURGICALLY IMPOSSIBLE CASE OF GIANT CORONARY ANEURYSM: A SUCCESSFUL CASE
Main Article Content
Keywords:
aneurisma, koroner, IVUS, intervensi, Covered stentAbstract
Giant coronary artery aneurysms (CAAs), defined as dilations exceeding 20 mm or four times the normal artery diameter, are rare clinical entities with limited management guidelines. Most cases are discovered incidentally, but complications can be life-threatening. Treatment remains controversial, with options including medical therapy, percutaneous intervention, and surgery. We report the case of a 64-year-old male with chest pain and high-risk NSTEMI, found to have a de novo giant saccular aneurysm in the mid-left anterior descending artery (LAD) through coronary CT angiography. Coronary angiography confirmed significant LAD and LCX stenosis alongside aneurysmal progression. Surgery was ruled out due to high intraoperative risk. After multidisciplinary deliberation, percutaneous coronary intervention (PCI) using overlapping covered stents was performed, successfully excluding the aneurysm. The patient’s condition stabilized post-procedure, and he was discharged in good condition with continued outpatient follow-up. This case demonstrates that percutaneous intervention with covered stents can be a safe and effective treatment for giant CAAs in select high-risk patients when surgical options are limited. It highlights the role of advanced imaging, intravascular ultrasound, and multidisciplinary decision-making in guiding individualized treatment. Further research is essential to establish optimal management strategies and long-term outcomes for patients with giant CAAs.
Article Details
References
1. Sheikh AS, Hailan A, Kinnaird T, Choudhury A, Smith D. Coronary Artery Aneurysm: Evaluation, Prognosis, and Proposed Treatment Strategies. Heart Views. 2019;20(3):101-8.
2. Ghazinour M, Ghaedi A, Bazrgar A, Montaseri M, Sasannia M, Bazrafshan Drissi H. A huge coronary artery aneurysm with ST-elevation myocardial infarction: A case report and review of literature. Heliyon. 2024;10(19):e38511.
3. Veenu J, Shetty GG, Adhyapak SM, Jayadev SM, Varghese K, Patil CB. Giant coronary artery aneurysms involving all three coronary arteries. Indian Heart J. 2014;66(6):727-30.
4. Abou Sherif S, Ozden Tok O, Taşköylü Ö, Goktekin O, Kilic ID. Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine. 2017;Volume 4 - 2017.
5. ElGuindy MS, ElGuindy AM. Aneurysmal coronary artery disease: An overview. Glob Cardiol Sci Pract. 2017;2017(3):e201726.
6. Thangathurai J, Kalashnikova M, Takahashi M, Shinbane JS. Coronary Artery Aneurysm in Kawasaki Disease: Coronary CT Angiography through the Lens of Pathophysiology and Differential Diagnosis. Radiol Cardiothorac Imaging. 2021;3(5):e200550.
7. Sannino M, Nicolai M, Infusino F, Giulio L, Usai TL, Biscotti G, et al. Coronary Artery Aneurysms: A Clinical Case Report and Literature Review Supporting Therapeutic Choices. J Clin Med. 2024;13(18).
8. Matta AG, Yaacoub N, Nader V, Moussallem N, Carrie D, Roncalli J. Coronary artery aneurysm: A review. World J Cardiol. 2021;13(9):446-55.
9. Esposito L, Di Maio M, Silverio A, Cancro FP, Bellino M, Attisano T, et al. Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma. Front Cardiovasc Med. 2021;8:805727.
10. Qin Y, Tang C, Ma C, Yan G. Risk factors for coronary artery ectasia and the relationship between hyperlipidemia and coronary artery ectasia. Coron Artery Dis. 2019;30(3):211-5.
11. Shanmuganathan G, Agrawal DK. Diabetes and Abdominal Aortic Aneurysm: Is the Protective Effect on AAA Due to Antidiabetic Medications Alone, Due to the Disease Alone, or Both? Arch Intern Med Res. 2024;7(2):104-13.
12. Güvenç R, Al Arfaj AA, Razouk H, Güvenç TS. Pathophysiology, Diagnosis, and Management of Coronary Artery Aneurysms: A Review. Rev Cardiovasc Med. 2025;26(8):39702.
13. Zhang HP, Yu X, Ji FS, Sun FC. Coronary artery aneurysm formation after drug-coated balloon treatment of de novo lesions: Two case reports. Medicine (Baltimore). 2018;97(45):e13208.
14. Pham V, Hemptinne Q, Grinda JM, Duboc D, Varenne O, Picard F. Giant coronary aneurysms, from diagnosis to treatment: A literature review. Arch Cardiovasc Dis. 2020;113(1):59-69.
15. Zhu X, Zhou Q, Tong S, Zhou Y. Challenges and strategies in the management of coronary artery aneurysms. Hellenic J Cardiol. 2021;62(2):112-20.
16. Kawsara A, Núñez Gil IJ, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of Coronary Artery Aneurysms. JACC Cardiovasc Interv. 2018;11(13):1211-23.
17. Núñez-Gil IJ, Terol B, Feltes G, Nombela-Franco L, Salinas P, Escaned J, et al. Coronary aneurysms in the acute patient: Incidence, characterization and long-term management results. Cardiovasc Revasc Med. 2018;19(5 Pt B):589-96.
18. Haokao G, Genrui C, Weiwei X, Wangwei Y, Chengxiang L. A Giant Coronary Aneurysm Formation After RCA CTO Recanalization. JACC Case Rep. 2025;30(10):103321.
19. Khubber S, Chana R, Meenakshisundaram C, Dhaliwal K, Gad M, Kaur M, et al. Coronary artery aneurysms: outcomes following medical, percutaneous interventional and surgical management. Open Heart. 2021;8(1).
20. Rostam-Alilou A, Safari M, Jarrah H, Zolfagharian A, Bodaghi M. A machine learning model for non-invasive detection of atherosclerotic coronary artery aneurysm. International Journal of Computer Assisted Radiology and Surgery. 2022;17.
